| Utility of physiologically based biopharmaceutics modeling (PBBM) in Regulatory Perspective: application to Supersede f2, enabling Biowaivers & Creation of Dissolution Safe Space AK Bhattiprolu, S Kollipara, T Ahmed, R Boddu, S Chachad Journal of Pharmaceutical Sciences 111 (12), 3397-3410, 2022 | 24 | 2022 |
| Best practices for integration of dissolution data into physiologically based biopharmaceutics models (PBBM): a biopharmaceutics modeling scientist perspective S Kollipara, AK Bhattiprolu, R Boddu, T Ahmed, S Chachad AAPS PharmSciTech 24 (2), 59, 2023 | 20 | 2023 |
| In vitro and In silico biopharmaceutic regulatory guidelines for generic bioequivalence for oral products: Comparison among various regulatory agencies S Kollipara, T Ahmed, AK Bhattiprolu, S Chachad Biopharmaceutics & Drug Disposition 42 (7), 297-318, 2021 | 16 | 2021 |
| Biopharmaceutics Risk Assessment—Connecting Critical Bioavailability Attributes with In Vitro,In Vivo Properties and Physiologically Based Biopharmaceutics … T Ahmed, S Kollipara, R Boddu, AK Bhattiprolu The AAPS Journal 25 (5), 77, 2023 | 15 | 2023 |
| Novel application of PBBM to justify impact of faster dissolution on safety and pharmacokinetics–a case study and utility in regulatory justifications R Boddu, S Kollipara, AK Bhattiprolu, T Ahmed Xenobiotica 53 (10-11), 587-602, 2023 | 5 | 2023 |
| A Semi-Mechanistic Physiologically Based Biopharmaceutics Model to Describe Complex and Saturable Absorption of Metformin: Justification of Dissolution Specifications for … AK Bhattiprolu, S Kollipara, R Boddu, A Arumugam, SM Khan, T Ahmed AAPS PharmSciTech 25 (7), 193, 2024 | 1 | 2024 |
| Dissolution Profiles Comparison Using Conventional and Bias Corrected and Accelerated f2 Bootstrap Approaches with Different Software’s: Impact of Variability, Sample Size and … R Boddu, S Kollipara, AK Bhattiprolu, K Parsa, SK Chakilam, KR Daka, ... AAPS PharmSciTech 25 (1), 5, 2023 | 1 | 2023 |
| Justification of Widened Dissolution Specifications of an Extended Release Product Using Physiologically Based Biopharmaceutics Modeling AK Bhattiprolu, S Kollipara, R Boddu, T Ahmed Xenobiotica, 1-18, 2024 | | 2024 |
| Model Independent and Dependent Methods for Dissolution Profiles Comparison: Can we take the Road Less Travelled? AK Bhattiprolu, S Kollipara, R Boddu, A Rachapally, T Ahmed International Journal of Pharmaceutical Sciences and Developmental Research …, 2024 | | 2024 |
| EBSCO Auth Banner S Kollipara, T Ahmed, AK Bhattiprolu, S Chachad | | |
